The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...

Genentech, a member of the Roche Group, announced that the FDA has approved the company’s TNKase (tenecteplase) thrombolytic ...

In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard ...

IV therapy has been used for decades in hospitals to treat a range of conditions, from dehydration to nutrient-absorption disorders, but it’s increasingly offered at independent clinics and ...

Karim Al-Hussaini, Aga Khan IV, the 49th hereditary Imam of the Shia Ismaili Muslims and a direct descendant of the Prophet Muhammad, passed away in Lisbon on 4 February 2025, aged 88. In a post on X, ...

Prince Karim Al-Hussaini, the Aga Khan IV and 49th hereditary imam of the Shiite Ismaili Muslims, died at his home in Lisbon, Portugal on Tuesday. He was 88 years old. The Aga Khan IV can trace ...

The United States has informed the United Nations (UN) that it is freezing some of the critical funds meant for the peacekeeping mission in Haiti. Addressing the press on Tuesday evening, the UN ...

The Aga Khan IV, a revered spiritual leader, philanthropist, and one of the world's wealthiest men, passed away at the age of 88 in Lisbon, Portugal. As the 49th hereditary Imam of the Shia ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

Born on Oct. 12, 1971, the U.S.-educated, Swiss-based Rahim is the eldest son of the Aga Khan IV and his first wife, Princess Salimah - née Sarah Croker Poole, a British ex-model. The couple had ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...